nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—Dinoprostone—PTGER4—ulcerative colitis	0.0108	1	CrCbGaD
Epoprostenol—PTGIS—smooth muscle tissue—ulcerative colitis	0.00609	0.21	CbGeAlD
Epoprostenol—P2RY12—epithelium—ulcerative colitis	0.00569	0.196	CbGeAlD
Epoprostenol—PTGIR—epithelium—ulcerative colitis	0.00363	0.125	CbGeAlD
Epoprostenol—PTGIS—liver—ulcerative colitis	0.00358	0.123	CbGeAlD
Epoprostenol—PTGIR—smooth muscle tissue—ulcerative colitis	0.0035	0.12	CbGeAlD
Epoprostenol—PTGIR—digestive system—ulcerative colitis	0.00276	0.0951	CbGeAlD
Epoprostenol—PTGIR—liver—ulcerative colitis	0.00206	0.0709	CbGeAlD
Epoprostenol—CYP2C9—digestive system—ulcerative colitis	0.000986	0.034	CbGeAlD
Epoprostenol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000921	0.00237	CbGpPWpGaD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.00092	0.00237	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—GNA12—ulcerative colitis	0.00092	0.00237	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CCR6—ulcerative colitis	0.000917	0.00236	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—ITGAL—ulcerative colitis	0.000903	0.00232	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCR2—ulcerative colitis	0.000898	0.00231	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000898	0.00231	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000893	0.0023	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000893	0.0023	CbGpPWpGaD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000877	0.00226	CbGpPWpGaD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000876	0.00225	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CHP1—ulcerative colitis	0.000869	0.00223	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000863	0.00222	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000863	0.00222	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000858	0.00221	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—GNA12—ulcerative colitis	0.000847	0.00218	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCR6—ulcerative colitis	0.000844	0.00217	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCR6—ulcerative colitis	0.000844	0.00217	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—ITGAL—ulcerative colitis	0.000831	0.00214	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SEL1L—ulcerative colitis	0.000824	0.00212	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000814	0.00209	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—PTGER4—ulcerative colitis	0.000807	0.00208	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000804	0.00207	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—STAT3—ulcerative colitis	0.000793	0.00204	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—DLD—ulcerative colitis	0.00075	0.00193	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000743	0.00191	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—PTGER4—ulcerative colitis	0.000743	0.00191	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00074	0.0019	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00074	0.0019	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—GHRL—ulcerative colitis	0.000739	0.0019	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—LTF—ulcerative colitis	0.000739	0.0019	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—TGFB1—ulcerative colitis	0.000735	0.00189	CbGpPWpGaD
Epoprostenol—CYP2C9—liver—ulcerative colitis	0.000735	0.0253	CbGeAlD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000704	0.00181	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—TNF—ulcerative colitis	0.000686	0.00176	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—GHRL—ulcerative colitis	0.00068	0.00175	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—GHRL—ulcerative colitis	0.00068	0.00175	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000648	0.00167	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000648	0.00167	CbGpPWpGaD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000645	0.00166	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—CALM3—ulcerative colitis	0.00064	0.00165	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCR1—ulcerative colitis	0.00064	0.00164	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CCL20—ulcerative colitis	0.000619	0.00159	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—ADRB2—ulcerative colitis	0.000612	0.00157	CbGpPWpGaD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.00061	0.00157	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	0.000604	0.00155	CbGpPWpGaD
Epoprostenol—Angiopathy—Dexamethasone—ulcerative colitis	0.000602	0.00106	CcSEcCtD
Epoprostenol—Rash—Budesonide—ulcerative colitis	0.000601	0.00105	CcSEcCtD
Epoprostenol—Dermatitis—Budesonide—ulcerative colitis	0.000601	0.00105	CcSEcCtD
Epoprostenol—Headache—Budesonide—ulcerative colitis	0.000597	0.00105	CcSEcCtD
Epoprostenol—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000594	0.00104	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—CALM3—ulcerative colitis	0.000589	0.00151	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000589	0.00151	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCR1—ulcerative colitis	0.000589	0.00151	CbGpPWpGaD
Epoprostenol—Bradycardia—Prednisone—ulcerative colitis	0.000588	0.00103	CcSEcCtD
Epoprostenol—Diarrhoea—Azathioprine—ulcerative colitis	0.000582	0.00102	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—GNA12—ulcerative colitis	0.000582	0.0015	CbGpPWpGaD
Epoprostenol—Haemoglobin—Prednisone—ulcerative colitis	0.00058	0.00102	CcSEcCtD
Epoprostenol—Haemorrhage—Prednisone—ulcerative colitis	0.000577	0.00101	CcSEcCtD
Epoprostenol—Myalgia—Hydrocortisone—ulcerative colitis	0.000575	0.00101	CcSEcCtD
Epoprostenol—Anxiety—Hydrocortisone—ulcerative colitis	0.000573	0.00101	CcSEcCtD
Epoprostenol—Hypersensitivity—Mesalazine—ulcerative colitis	0.000571	0.001	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000571	0.001	CcSEcCtD
Epoprostenol—Syncope—Triamcinolone—ulcerative colitis	0.00057	0.001	CcSEcCtD
Epoprostenol—Syncope—Methylprednisolone—ulcerative colitis	0.000569	0.000998	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000569	0.00146	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCL20—ulcerative colitis	0.000569	0.00146	CbGpPWpGaD
Epoprostenol—Connective tissue disorder—Prednisone—ulcerative colitis	0.000567	0.000995	CcSEcCtD
Epoprostenol—Nausea—Budesonide—ulcerative colitis	0.000566	0.000993	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000565	0.00099	CcSEcCtD
Epoprostenol—Oedema—Prednisolone—ulcerative colitis	0.000565	0.00099	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000563	0.00145	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—ADRB2—ulcerative colitis	0.000563	0.00145	CbGpPWpGaD
Epoprostenol—Dizziness—Azathioprine—ulcerative colitis	0.000563	0.000987	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000562	0.00144	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL20—ulcerative colitis	0.000562	0.00144	CbGpPWpGaD
Epoprostenol—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000559	0.000981	CcSEcCtD
Epoprostenol—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000558	0.000978	CcSEcCtD
Epoprostenol—Asthenia—Mesalazine—ulcerative colitis	0.000556	0.000976	CcSEcCtD
Epoprostenol—Shock—Prednisolone—ulcerative colitis	0.000555	0.000974	CcSEcCtD
Epoprostenol—Cough—Triamcinolone—ulcerative colitis	0.000555	0.000974	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—IL6—ulcerative colitis	0.000554	0.00142	CbGpPWpGaD
Epoprostenol—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000551	0.000967	CcSEcCtD
Epoprostenol—Oedema—Hydrocortisone—ulcerative colitis	0.000551	0.000967	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000551	0.00142	CbGpPWpGaD
Epoprostenol—Tachycardia—Prednisolone—ulcerative colitis	0.000551	0.000966	CcSEcCtD
Epoprostenol—Pruritus—Mesalazine—ulcerative colitis	0.000549	0.000962	CcSEcCtD
Epoprostenol—Infection—Hydrocortisone—ulcerative colitis	0.000548	0.000961	CcSEcCtD
Epoprostenol—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000546	0.000957	CcSEcCtD
Epoprostenol—Shock—Hydrocortisone—ulcerative colitis	0.000542	0.000951	CcSEcCtD
Epoprostenol—Myalgia—Triamcinolone—ulcerative colitis	0.000542	0.00095	CcSEcCtD
Epoprostenol—Vomiting—Azathioprine—ulcerative colitis	0.000541	0.000949	CcSEcCtD
Epoprostenol—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000541	0.000948	CcSEcCtD
Epoprostenol—Arthralgia—Methylprednisolone—ulcerative colitis	0.00054	0.000948	CcSEcCtD
Epoprostenol—Myalgia—Methylprednisolone—ulcerative colitis	0.00054	0.000948	CcSEcCtD
Epoprostenol—Anxiety—Methylprednisolone—ulcerative colitis	0.000539	0.000944	CcSEcCtD
Epoprostenol—Tachycardia—Hydrocortisone—ulcerative colitis	0.000538	0.000944	CcSEcCtD
Epoprostenol—Rash—Azathioprine—ulcerative colitis	0.000537	0.000941	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000537	0.000941	CcSEcCtD
Epoprostenol—Dermatitis—Azathioprine—ulcerative colitis	0.000536	0.00094	CcSEcCtD
Epoprostenol—Flushing—Prednisone—ulcerative colitis	0.000536	0.00094	CcSEcCtD
Epoprostenol—Skin disorder—Hydrocortisone—ulcerative colitis	0.000536	0.000939	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000535	0.00138	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—GNA12—ulcerative colitis	0.000535	0.00138	CbGpPWpGaD
Epoprostenol—Headache—Azathioprine—ulcerative colitis	0.000533	0.000935	CcSEcCtD
Epoprostenol—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000533	0.000935	CcSEcCtD
Epoprostenol—Diarrhoea—Mesalazine—ulcerative colitis	0.000531	0.00093	CcSEcCtD
Epoprostenol—Dry mouth—Triamcinolone—ulcerative colitis	0.00053	0.000929	CcSEcCtD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000529	0.00136	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—GNA12—ulcerative colitis	0.000528	0.00136	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SLC11A1—ulcerative colitis	0.000527	0.00135	CbGpPWpGaD
Epoprostenol—Anorexia—Hydrocortisone—ulcerative colitis	0.000526	0.000922	CcSEcCtD
Epoprostenol—Angiopathy—Prednisone—ulcerative colitis	0.000524	0.000919	CcSEcCtD
Epoprostenol—Confusional state—Methylprednisolone—ulcerative colitis	0.000522	0.000916	CcSEcCtD
Epoprostenol—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000519	0.000911	CcSEcCtD
Epoprostenol—Oedema—Triamcinolone—ulcerative colitis	0.000519	0.000911	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—CCR6—ulcerative colitis	0.000518	0.00133	CbGpPWpGaD
Epoprostenol—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000518	0.000909	CcSEcCtD
Epoprostenol—Syncope—Betamethasone—ulcerative colitis	0.000518	0.000908	CcSEcCtD
Epoprostenol—Syncope—Dexamethasone—ulcerative colitis	0.000518	0.000908	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—CCL20—ulcerative colitis	0.000517	0.00133	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL20—ulcerative colitis	0.000517	0.00133	CbGpPWpGaD
Epoprostenol—Infection—Triamcinolone—ulcerative colitis	0.000516	0.000905	CcSEcCtD
Epoprostenol—Hypotension—Hydrocortisone—ulcerative colitis	0.000515	0.000904	CcSEcCtD
Epoprostenol—Infection—Methylprednisolone—ulcerative colitis	0.000515	0.000903	CcSEcCtD
Epoprostenol—Dizziness—Mesalazine—ulcerative colitis	0.000513	0.000899	CcSEcCtD
Epoprostenol—Shock—Triamcinolone—ulcerative colitis	0.000511	0.000896	CcSEcCtD
Epoprostenol—Insomnia—Prednisolone—ulcerative colitis	0.000511	0.000896	CcSEcCtD
Epoprostenol—Shock—Methylprednisolone—ulcerative colitis	0.00051	0.000894	CcSEcCtD
Epoprostenol—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000508	0.000891	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000507	0.0013	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000507	0.0013	CbGpPWpGaD
Epoprostenol—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000507	0.00089	CcSEcCtD
Epoprostenol—Loss of consciousness—Betamethasone—ulcerative colitis	0.000507	0.00089	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisolone—ulcerative colitis	0.000507	0.000889	CcSEcCtD
Epoprostenol—Tachycardia—Triamcinolone—ulcerative colitis	0.000507	0.000889	CcSEcCtD
Epoprostenol—Mental disorder—Prednisone—ulcerative colitis	0.000506	0.000887	CcSEcCtD
Epoprostenol—Nausea—Azathioprine—ulcerative colitis	0.000506	0.000887	CcSEcCtD
Epoprostenol—Tachycardia—Methylprednisolone—ulcerative colitis	0.000506	0.000887	CcSEcCtD
Epoprostenol—Skin disorder—Methylprednisolone—ulcerative colitis	0.000503	0.000883	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000502	0.000881	CcSEcCtD
Epoprostenol—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000502	0.00088	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000501	0.000878	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CXCR2—ulcerative colitis	0.000501	0.00129	CbGpPWpGaD
Epoprostenol—Insomnia—Hydrocortisone—ulcerative colitis	0.000499	0.000875	CcSEcCtD
Epoprostenol—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000495	0.000868	CcSEcCtD
Epoprostenol—Vomiting—Mesalazine—ulcerative colitis	0.000493	0.000865	CcSEcCtD
Epoprostenol—Myalgia—Betamethasone—ulcerative colitis	0.000491	0.000862	CcSEcCtD
Epoprostenol—Myalgia—Dexamethasone—ulcerative colitis	0.000491	0.000862	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	0.00049	0.00126	CbGpPWpGaD
Epoprostenol—Anxiety—Dexamethasone—ulcerative colitis	0.00049	0.000859	CcSEcCtD
Epoprostenol—Anxiety—Betamethasone—ulcerative colitis	0.00049	0.000859	CcSEcCtD
Epoprostenol—Rash—Mesalazine—ulcerative colitis	0.000489	0.000857	CcSEcCtD
Epoprostenol—Dermatitis—Mesalazine—ulcerative colitis	0.000488	0.000857	CcSEcCtD
Epoprostenol—P2RY12—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000488	0.00125	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—GNA12—ulcerative colitis	0.000486	0.00125	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—GNA12—ulcerative colitis	0.000486	0.00125	CbGpPWpGaD
Epoprostenol—Headache—Mesalazine—ulcerative colitis	0.000486	0.000852	CcSEcCtD
Epoprostenol—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000485	0.000851	CcSEcCtD
Epoprostenol—Hypotension—Methylprednisolone—ulcerative colitis	0.000484	0.000849	CcSEcCtD
Epoprostenol—Pain—Prednisolone—ulcerative colitis	0.000483	0.000847	CcSEcCtD
Epoprostenol—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000479	0.000841	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—CCR6—ulcerative colitis	0.000477	0.00123	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000477	0.00123	CbGpPWpGaD
Epoprostenol—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000476	0.000835	CcSEcCtD
Epoprostenol—Fatigue—Hydrocortisone—ulcerative colitis	0.000475	0.000834	CcSEcCtD
Epoprostenol—PTGIS—Disease—MAML2—ulcerative colitis	0.000473	0.00122	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000473	0.00083	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000472	0.000828	CcSEcCtD
Epoprostenol—Pain—Hydrocortisone—ulcerative colitis	0.000472	0.000827	CcSEcCtD
Epoprostenol—Oedema—Betamethasone—ulcerative colitis	0.000471	0.000826	CcSEcCtD
Epoprostenol—Oedema—Dexamethasone—ulcerative colitis	0.000471	0.000826	CcSEcCtD
Epoprostenol—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000471	0.000826	CcSEcCtD
Epoprostenol—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000471	0.000826	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CCR6—ulcerative colitis	0.000471	0.00121	CbGpPWpGaD
Epoprostenol—Insomnia—Triamcinolone—ulcerative colitis	0.00047	0.000824	CcSEcCtD
Epoprostenol—Insomnia—Methylprednisolone—ulcerative colitis	0.000469	0.000822	CcSEcCtD
Epoprostenol—Infection—Betamethasone—ulcerative colitis	0.000468	0.000821	CcSEcCtD
Epoprostenol—Infection—Dexamethasone—ulcerative colitis	0.000468	0.000821	CcSEcCtD
Epoprostenol—Paraesthesia—Triamcinolone—ulcerative colitis	0.000466	0.000818	CcSEcCtD
Epoprostenol—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000465	0.000816	CcSEcCtD
Epoprostenol—Anaemia—Prednisone—ulcerative colitis	0.000465	0.000815	CcSEcCtD
Epoprostenol—Shock—Betamethasone—ulcerative colitis	0.000463	0.000813	CcSEcCtD
Epoprostenol—Shock—Dexamethasone—ulcerative colitis	0.000463	0.000813	CcSEcCtD
Epoprostenol—Dyspnoea—Triamcinolone—ulcerative colitis	0.000463	0.000812	CcSEcCtD
Epoprostenol—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000462	0.00081	CcSEcCtD
Epoprostenol—Nervous system disorder—Betamethasone—ulcerative colitis	0.000462	0.00081	CcSEcCtD
Epoprostenol—Agitation—Prednisone—ulcerative colitis	0.000462	0.00081	CcSEcCtD
Epoprostenol—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000461	0.000809	CcSEcCtD
Epoprostenol—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000461	0.000809	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—CXCR2—ulcerative colitis	0.000461	0.00118	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000461	0.00118	CbGpPWpGaD
Epoprostenol—Nausea—Mesalazine—ulcerative colitis	0.000461	0.000808	CcSEcCtD
Epoprostenol—Tachycardia—Dexamethasone—ulcerative colitis	0.00046	0.000806	CcSEcCtD
Epoprostenol—Tachycardia—Betamethasone—ulcerative colitis	0.00046	0.000806	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—SEL1L—ulcerative colitis	0.000459	0.00118	CbGpPWpGaD
Epoprostenol—Dyspepsia—Triamcinolone—ulcerative colitis	0.000457	0.000802	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000456	0.00117	CbGpPWpGaD
Epoprostenol—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000456	0.0008	CcSEcCtD
Epoprostenol—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000455	0.000799	CcSEcCtD
Epoprostenol—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000455	0.000799	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000451	0.000791	CcSEcCtD
Epoprostenol—Syncope—Prednisone—ulcerative colitis	0.000451	0.000791	CcSEcCtD
Epoprostenol—Anorexia—Dexamethasone—ulcerative colitis	0.000449	0.000788	CcSEcCtD
Epoprostenol—Anorexia—Betamethasone—ulcerative colitis	0.000449	0.000788	CcSEcCtD
Epoprostenol—Urticaria—Prednisolone—ulcerative colitis	0.000449	0.000787	CcSEcCtD
Epoprostenol—Fatigue—Triamcinolone—ulcerative colitis	0.000448	0.000785	CcSEcCtD
Epoprostenol—Fatigue—Methylprednisolone—ulcerative colitis	0.000447	0.000783	CcSEcCtD
Epoprostenol—Pain—Triamcinolone—ulcerative colitis	0.000444	0.000779	CcSEcCtD
Epoprostenol—Loss of consciousness—Prednisone—ulcerative colitis	0.000442	0.000775	CcSEcCtD
Epoprostenol—Hypotension—Betamethasone—ulcerative colitis	0.00044	0.000772	CcSEcCtD
Epoprostenol—Hypotension—Dexamethasone—ulcerative colitis	0.00044	0.000772	CcSEcCtD
Epoprostenol—Urticaria—Hydrocortisone—ulcerative colitis	0.000438	0.000768	CcSEcCtD
Epoprostenol—CYP2C9—Nicotine—ulcerative colitis	0.000437	0.438	CbGbCtD
Epoprostenol—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000436	0.000764	CcSEcCtD
Epoprostenol—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000436	0.000764	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—CCR6—ulcerative colitis	0.000433	0.00111	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCR6—ulcerative colitis	0.000433	0.00111	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000429	0.000753	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000429	0.000753	CcSEcCtD
Epoprostenol—Myalgia—Prednisone—ulcerative colitis	0.000428	0.000751	CcSEcCtD
Epoprostenol—Arthralgia—Prednisone—ulcerative colitis	0.000428	0.000751	CcSEcCtD
Epoprostenol—Anxiety—Prednisone—ulcerative colitis	0.000426	0.000748	CcSEcCtD
Epoprostenol—Insomnia—Betamethasone—ulcerative colitis	0.000426	0.000747	CcSEcCtD
Epoprostenol—Insomnia—Dexamethasone—ulcerative colitis	0.000426	0.000747	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000425	0.000745	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000424	0.000743	CcSEcCtD
Epoprostenol—Paraesthesia—Betamethasone—ulcerative colitis	0.000423	0.000742	CcSEcCtD
Epoprostenol—Paraesthesia—Dexamethasone—ulcerative colitis	0.000423	0.000742	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—SEL1L—ulcerative colitis	0.000422	0.00109	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SEL1L—ulcerative colitis	0.000422	0.00109	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00042	0.00108	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00042	0.00108	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—GHRL—ulcerative colitis	0.000418	0.00107	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Prednisolone—ulcerative colitis	0.000416	0.00073	CcSEcCtD
Epoprostenol—Dyspepsia—Dexamethasone—ulcerative colitis	0.000415	0.000727	CcSEcCtD
Epoprostenol—Dyspepsia—Betamethasone—ulcerative colitis	0.000415	0.000727	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—PTGER4—ulcerative colitis	0.000414	0.00107	CbGpPWpGaD
Epoprostenol—Urticaria—Triamcinolone—ulcerative colitis	0.000412	0.000723	CcSEcCtD
Epoprostenol—Urticaria—Methylprednisolone—ulcerative colitis	0.000412	0.000722	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—MMP1—ulcerative colitis	0.000411	0.00106	CbGpPWpGaD
Epoprostenol—Body temperature increased—Triamcinolone—ulcerative colitis	0.00041	0.00072	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisone—ulcerative colitis	0.00041	0.00072	CcSEcCtD
Epoprostenol—Oedema—Prednisone—ulcerative colitis	0.00041	0.00072	CcSEcCtD
Epoprostenol—Abdominal pain—Methylprednisolone—ulcerative colitis	0.00041	0.000718	CcSEcCtD
Epoprostenol—Decreased appetite—Dexamethasone—ulcerative colitis	0.00041	0.000718	CcSEcCtD
Epoprostenol—Decreased appetite—Betamethasone—ulcerative colitis	0.00041	0.000718	CcSEcCtD
Epoprostenol—Infection—Prednisone—ulcerative colitis	0.000408	0.000715	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000407	0.000713	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000407	0.000713	CcSEcCtD
Epoprostenol—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000406	0.000712	CcSEcCtD
Epoprostenol—Fatigue—Dexamethasone—ulcerative colitis	0.000406	0.000712	CcSEcCtD
Epoprostenol—Fatigue—Betamethasone—ulcerative colitis	0.000406	0.000712	CcSEcCtD
Epoprostenol—Shock—Prednisone—ulcerative colitis	0.000404	0.000708	CcSEcCtD
Epoprostenol—Pain—Dexamethasone—ulcerative colitis	0.000403	0.000707	CcSEcCtD
Epoprostenol—Pain—Betamethasone—ulcerative colitis	0.000403	0.000707	CcSEcCtD
Epoprostenol—Nervous system disorder—Prednisone—ulcerative colitis	0.000402	0.000706	CcSEcCtD
Epoprostenol—Tachycardia—Prednisone—ulcerative colitis	0.0004	0.000702	CcSEcCtD
Epoprostenol—Skin disorder—Prednisone—ulcerative colitis	0.000398	0.000699	CcSEcCtD
Epoprostenol—Hyperhidrosis—Prednisone—ulcerative colitis	0.000397	0.000696	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	0.000397	0.00102	CbGpPWpGaD
Epoprostenol—Asthenia—Hydrocortisone—ulcerative colitis	0.000396	0.000694	CcSEcCtD
Epoprostenol—CYP2C9—Cholecalciferol—ulcerative colitis	0.000392	0.392	CbGbCtD
Epoprostenol—Anorexia—Prednisone—ulcerative colitis	0.000391	0.000686	CcSEcCtD
Epoprostenol—Pruritus—Hydrocortisone—ulcerative colitis	0.00039	0.000684	CcSEcCtD
Epoprostenol—PTGIS—Disease—CALM3—ulcerative colitis	0.00039	0.001	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000388	0.000998	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000385	0.000676	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000385	0.000676	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—GHRL—ulcerative colitis	0.000384	0.000988	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000384	0.000988	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000383	0.000671	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	0.000382	0.000983	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000382	0.000669	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000381	0.00098	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PTGER4—ulcerative colitis	0.000381	0.00098	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—GHRL—ulcerative colitis	0.000379	0.000975	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—MMP1—ulcerative colitis	0.000378	0.000972	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCR1—ulcerative colitis	0.000378	0.000972	CbGpPWpGaD
Epoprostenol—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000377	0.000662	CcSEcCtD
Epoprostenol—Urticaria—Betamethasone—ulcerative colitis	0.000374	0.000656	CcSEcCtD
Epoprostenol—Urticaria—Dexamethasone—ulcerative colitis	0.000374	0.000656	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000374	0.000656	CcSEcCtD
Epoprostenol—Dizziness—Prednisolone—ulcerative colitis	0.000373	0.000655	CcSEcCtD
Epoprostenol—Asthenia—Triamcinolone—ulcerative colitis	0.000373	0.000653	CcSEcCtD
Epoprostenol—Body temperature increased—Betamethasone—ulcerative colitis	0.000372	0.000653	CcSEcCtD
Epoprostenol—Abdominal pain—Dexamethasone—ulcerative colitis	0.000372	0.000653	CcSEcCtD
Epoprostenol—Body temperature increased—Dexamethasone—ulcerative colitis	0.000372	0.000653	CcSEcCtD
Epoprostenol—Abdominal pain—Betamethasone—ulcerative colitis	0.000372	0.000653	CcSEcCtD
Epoprostenol—Asthenia—Methylprednisolone—ulcerative colitis	0.000372	0.000652	CcSEcCtD
Epoprostenol—Insomnia—Prednisone—ulcerative colitis	0.000371	0.000651	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisone—ulcerative colitis	0.000368	0.000646	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CALM3—ulcerative colitis	0.000367	0.000945	CbGpPWpGaD
Epoprostenol—Pruritus—Triamcinolone—ulcerative colitis	0.000367	0.000644	CcSEcCtD
Epoprostenol—Pruritus—Methylprednisolone—ulcerative colitis	0.000367	0.000643	CcSEcCtD
Epoprostenol—Dizziness—Hydrocortisone—ulcerative colitis	0.000365	0.000639	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—PTGS1—ulcerative colitis	0.000363	0.000932	CbGpPWpGaD
Epoprostenol—Dyspepsia—Prednisone—ulcerative colitis	0.000361	0.000633	CcSEcCtD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000357	0.000918	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000357	0.000918	CbGpPWpGaD
Epoprostenol—Decreased appetite—Prednisone—ulcerative colitis	0.000357	0.000625	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	0.000357	0.000917	CbGpPWpGaD
Epoprostenol—Rash—Prednisolone—ulcerative colitis	0.000356	0.000624	CcSEcCtD
Epoprostenol—Dermatitis—Prednisolone—ulcerative colitis	0.000356	0.000624	CcSEcCtD
Epoprostenol—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000354	0.000622	CcSEcCtD
Epoprostenol—Fatigue—Prednisone—ulcerative colitis	0.000354	0.00062	CcSEcCtD
Epoprostenol—Headache—Prednisolone—ulcerative colitis	0.000354	0.00062	CcSEcCtD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000353	0.000907	CbGpPWpGaD
Epoprostenol—Constipation—Prednisone—ulcerative colitis	0.000351	0.000615	CcSEcCtD
Epoprostenol—Vomiting—Hydrocortisone—ulcerative colitis	0.000351	0.000615	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—GHRL—ulcerative colitis	0.000349	0.000898	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—GHRL—ulcerative colitis	0.000349	0.000898	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCR1—ulcerative colitis	0.000348	0.000894	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCR1—ulcerative colitis	0.000348	0.000894	CbGpPWpGaD
Epoprostenol—Rash—Hydrocortisone—ulcerative colitis	0.000348	0.00061	CcSEcCtD
Epoprostenol—Dermatitis—Hydrocortisone—ulcerative colitis	0.000347	0.000609	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000346	0.000889	CbGpPWpGaD
Epoprostenol—Headache—Hydrocortisone—ulcerative colitis	0.000345	0.000606	CcSEcCtD
Epoprostenol—Dizziness—Triamcinolone—ulcerative colitis	0.000343	0.000602	CcSEcCtD
Epoprostenol—Dizziness—Methylprednisolone—ulcerative colitis	0.000343	0.000601	CcSEcCtD
Epoprostenol—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	0.000343	0.000881	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CALM3—ulcerative colitis	0.000338	0.000869	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CALM3—ulcerative colitis	0.000338	0.000869	CbGpPWpGaD
Epoprostenol—Asthenia—Dexamethasone—ulcerative colitis	0.000338	0.000593	CcSEcCtD
Epoprostenol—Asthenia—Betamethasone—ulcerative colitis	0.000338	0.000593	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000335	0.000588	CcSEcCtD
Epoprostenol—Nausea—Prednisolone—ulcerative colitis	0.000335	0.000588	CcSEcCtD
Epoprostenol—Pruritus—Betamethasone—ulcerative colitis	0.000333	0.000585	CcSEcCtD
Epoprostenol—Pruritus—Dexamethasone—ulcerative colitis	0.000333	0.000585	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—CCL20—ulcerative colitis	0.000332	0.000853	CbGpPWpGaD
Epoprostenol—Vomiting—Triamcinolone—ulcerative colitis	0.00033	0.000579	CcSEcCtD
Epoprostenol—Vomiting—Methylprednisolone—ulcerative colitis	0.000329	0.000578	CcSEcCtD
Epoprostenol—Nausea—Hydrocortisone—ulcerative colitis	0.000328	0.000574	CcSEcCtD
Epoprostenol—Rash—Triamcinolone—ulcerative colitis	0.000327	0.000574	CcSEcCtD
Epoprostenol—Dermatitis—Triamcinolone—ulcerative colitis	0.000327	0.000574	CcSEcCtD
Epoprostenol—Rash—Methylprednisolone—ulcerative colitis	0.000327	0.000573	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—CALM3—ulcerative colitis	0.000326	0.000839	CbGpPWpGaD
Epoprostenol—Dermatitis—Methylprednisolone—ulcerative colitis	0.000326	0.000572	CcSEcCtD
Epoprostenol—Urticaria—Prednisone—ulcerative colitis	0.000326	0.000572	CcSEcCtD
Epoprostenol—Headache—Triamcinolone—ulcerative colitis	0.000325	0.00057	CcSEcCtD
Epoprostenol—Headache—Methylprednisolone—ulcerative colitis	0.000325	0.000569	CcSEcCtD
Epoprostenol—Abdominal pain—Prednisone—ulcerative colitis	0.000324	0.000569	CcSEcCtD
Epoprostenol—Body temperature increased—Prednisone—ulcerative colitis	0.000324	0.000569	CcSEcCtD
Epoprostenol—Diarrhoea—Dexamethasone—ulcerative colitis	0.000322	0.000565	CcSEcCtD
Epoprostenol—Diarrhoea—Betamethasone—ulcerative colitis	0.000322	0.000565	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000318	0.000818	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000318	0.000818	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—ADRB2—ulcerative colitis	0.000314	0.000807	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GNA12—ulcerative colitis	0.000312	0.000802	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	0.000312	0.000802	CbGpPWpGaD
Epoprostenol—Dizziness—Dexamethasone—ulcerative colitis	0.000312	0.000546	CcSEcCtD
Epoprostenol—Dizziness—Betamethasone—ulcerative colitis	0.000312	0.000546	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—ALB—ulcerative colitis	0.000311	0.000801	CbGpPWpGaD
Epoprostenol—Nausea—Triamcinolone—ulcerative colitis	0.000308	0.000541	CcSEcCtD
Epoprostenol—Nausea—Methylprednisolone—ulcerative colitis	0.000308	0.00054	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CCL20—ulcerative colitis	0.000305	0.000785	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL20—ulcerative colitis	0.000305	0.000785	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Prednisone—ulcerative colitis	0.000302	0.00053	CcSEcCtD
Epoprostenol—Vomiting—Dexamethasone—ulcerative colitis	0.0003	0.000525	CcSEcCtD
Epoprostenol—Vomiting—Betamethasone—ulcerative colitis	0.0003	0.000525	CcSEcCtD
Epoprostenol—Rash—Betamethasone—ulcerative colitis	0.000297	0.000521	CcSEcCtD
Epoprostenol—Rash—Dexamethasone—ulcerative colitis	0.000297	0.000521	CcSEcCtD
Epoprostenol—Dermatitis—Dexamethasone—ulcerative colitis	0.000297	0.00052	CcSEcCtD
Epoprostenol—Dermatitis—Betamethasone—ulcerative colitis	0.000297	0.00052	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—CXCR2—ulcerative colitis	0.000296	0.00076	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CXCL8—ulcerative colitis	0.000296	0.00076	CbGpPWpGaD
Epoprostenol—Headache—Dexamethasone—ulcerative colitis	0.000295	0.000518	CcSEcCtD
Epoprostenol—Headache—Betamethasone—ulcerative colitis	0.000295	0.000518	CcSEcCtD
Epoprostenol—Asthenia—Prednisone—ulcerative colitis	0.000294	0.000516	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000294	0.000755	CbGpPWpGaD
Epoprostenol—Pruritus—Prednisone—ulcerative colitis	0.00029	0.000509	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—JAK2—ulcerative colitis	0.00029	0.000744	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000289	0.000743	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—ADRB2—ulcerative colitis	0.000289	0.000743	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GNA12—ulcerative colitis	0.000287	0.000738	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GNA12—ulcerative colitis	0.000287	0.000738	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—ALB—ulcerative colitis	0.000287	0.000737	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—ADCY5—ulcerative colitis	0.000283	0.000727	CbGpPWpGaD
Epoprostenol—Diarrhoea—Prednisone—ulcerative colitis	0.000281	0.000492	CcSEcCtD
Epoprostenol—Nausea—Betamethasone—ulcerative colitis	0.00028	0.000491	CcSEcCtD
Epoprostenol—Nausea—Dexamethasone—ulcerative colitis	0.00028	0.000491	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—CCR6—ulcerative colitis	0.000278	0.000715	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCR2—ulcerative colitis	0.000272	0.0007	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCR2—ulcerative colitis	0.000272	0.0007	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000272	0.000699	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCL8—ulcerative colitis	0.000272	0.000699	CbGpPWpGaD
Epoprostenol—Dizziness—Prednisone—ulcerative colitis	0.000271	0.000476	CcSEcCtD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000271	0.000697	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00027	0.000695	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00027	0.000695	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—ADCY5—ulcerative colitis	0.000267	0.000685	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—JAK2—ulcerative colitis	0.000266	0.000685	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAML2—ulcerative colitis	0.000264	0.000678	CbGpPWpGaD
Epoprostenol—Vomiting—Prednisone—ulcerative colitis	0.000261	0.000457	CcSEcCtD
Epoprostenol—Rash—Prednisone—ulcerative colitis	0.000259	0.000454	CcSEcCtD
Epoprostenol—Dermatitis—Prednisone—ulcerative colitis	0.000258	0.000453	CcSEcCtD
Epoprostenol—Headache—Prednisone—ulcerative colitis	0.000257	0.000451	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CCR6—ulcerative colitis	0.000256	0.000658	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR6—ulcerative colitis	0.000256	0.000658	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ABCB1—ulcerative colitis	0.000254	0.000653	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IL2—ulcerative colitis	0.000253	0.000649	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000245	0.000631	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—ADCY5—ulcerative colitis	0.000245	0.000631	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTGER4—ulcerative colitis	0.000245	0.000629	CbGpPWpGaD
Epoprostenol—Nausea—Prednisone—ulcerative colitis	0.000244	0.000427	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—MAML2—ulcerative colitis	0.000243	0.000624	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAML2—ulcerative colitis	0.000243	0.000624	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ADCY5—ulcerative colitis	0.000237	0.000609	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL2—ulcerative colitis	0.000232	0.000598	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTGER4—ulcerative colitis	0.000225	0.000579	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTGER4—ulcerative colitis	0.000225	0.000579	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GHRL—ulcerative colitis	0.000224	0.000576	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CALM3—ulcerative colitis	0.000217	0.000558	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RIPK2—ulcerative colitis	0.000214	0.00055	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GHRL—ulcerative colitis	0.000206	0.00053	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GHRL—ulcerative colitis	0.000206	0.00053	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CALM3—ulcerative colitis	0.0002	0.000514	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CALM3—ulcerative colitis	0.0002	0.000514	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TGFB1—ulcerative colitis	0.000197	0.000507	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RIPK2—ulcerative colitis	0.000197	0.000506	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RIPK2—ulcerative colitis	0.000197	0.000506	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADRB2—ulcerative colitis	0.000186	0.000477	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—JAK2—ulcerative colitis	0.000183	0.00047	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TGFB1—ulcerative colitis	0.000181	0.000466	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARG—ulcerative colitis	0.000177	0.000454	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—JAK2—ulcerative colitis	0.000176	0.000453	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRB2—ulcerative colitis	0.000171	0.000439	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRB2—ulcerative colitis	0.000171	0.000439	CbGpPWpGaD
Epoprostenol—CYP2C9—Dexamethasone—ulcerative colitis	0.00017	0.17	CbGbCtD
Epoprostenol—PTGIR—GPCR downstream signaling—JAK2—ulcerative colitis	0.000168	0.000433	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000168	0.000433	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD4—ulcerative colitis	0.000167	0.00043	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000167	0.000429	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—JAK2—ulcerative colitis	0.000166	0.000427	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—ulcerative colitis	0.000166	0.000426	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—ulcerative colitis	0.000162	0.000417	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—ulcerative colitis	0.00016	0.00041	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ALB—ulcerative colitis	0.000159	0.000408	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADCY5—ulcerative colitis	0.000157	0.000405	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000154	0.000395	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000154	0.000395	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—JAK2—ulcerative colitis	0.000153	0.000393	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—JAK2—ulcerative colitis	0.000153	0.000393	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL8—ulcerative colitis	0.000152	0.00039	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—ulcerative colitis	0.000149	0.000384	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—ulcerative colitis	0.000147	0.000378	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—ulcerative colitis	0.000147	0.000378	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—ulcerative colitis	0.000145	0.000373	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADCY5—ulcerative colitis	0.000145	0.000373	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADCY5—ulcerative colitis	0.000145	0.000373	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CHP1—ulcerative colitis	0.00014	0.000361	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL8—ulcerative colitis	0.00014	0.000359	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL8—ulcerative colitis	0.00014	0.000359	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—ulcerative colitis	0.000139	0.000357	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—ulcerative colitis	0.000133	0.000343	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—ulcerative colitis	0.000133	0.000343	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000132	0.000338	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—STAT3—ulcerative colitis	0.000129	0.000333	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DLD—ulcerative colitis	0.000121	0.000312	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—ulcerative colitis	0.00012	0.000308	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—JAK2—ulcerative colitis	9.82e-05	0.000252	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RELA—ulcerative colitis	9.51e-05	0.000244	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—ulcerative colitis	9.04e-05	0.000232	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—JAK2—ulcerative colitis	9.03e-05	0.000232	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—JAK2—ulcerative colitis	9.03e-05	0.000232	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL8—ulcerative colitis	8.96e-05	0.00023	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RELA—ulcerative colitis	8.75e-05	0.000225	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RELA—ulcerative colitis	8.75e-05	0.000225	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—ulcerative colitis	8.56e-05	0.00022	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—ulcerative colitis	8.52e-05	0.000219	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL8—ulcerative colitis	8.25e-05	0.000212	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL8—ulcerative colitis	8.25e-05	0.000212	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—ulcerative colitis	8.1e-05	0.000208	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NFKB1—ulcerative colitis	8.02e-05	0.000206	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—ulcerative colitis	7.88e-05	0.000203	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—ulcerative colitis	7.88e-05	0.000203	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—ulcerative colitis	7.84e-05	0.000202	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—ulcerative colitis	7.84e-05	0.000202	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—ulcerative colitis	7.46e-05	0.000192	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—ulcerative colitis	7.46e-05	0.000192	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NFKB1—ulcerative colitis	7.38e-05	0.00019	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NFKB1—ulcerative colitis	7.38e-05	0.00019	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—STAT3—ulcerative colitis	7.21e-05	0.000185	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—ulcerative colitis	6.68e-05	0.000172	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STAT3—ulcerative colitis	6.63e-05	0.00017	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—STAT3—ulcerative colitis	6.63e-05	0.00017	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.41e-05	0.000165	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—ulcerative colitis	6.15e-05	0.000158	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—ulcerative colitis	6.15e-05	0.000158	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS1—ulcerative colitis	5.86e-05	0.000151	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.76e-05	0.000148	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—ulcerative colitis	5.5e-05	0.000141	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CALM3—ulcerative colitis	5.27e-05	0.000136	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—ulcerative colitis	5.06e-05	0.00013	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—ulcerative colitis	5.06e-05	0.00013	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.04e-05	0.00013	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—ulcerative colitis	5.03e-05	0.000129	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—ulcerative colitis	4.63e-05	0.000119	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—ulcerative colitis	4.63e-05	0.000119	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ABCB1—ulcerative colitis	4.1e-05	0.000105	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.83e-05	9.84e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.85e-05	7.34e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—ulcerative colitis	2.57e-05	6.6e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.24e-05	5.77e-05	CbGpPWpGaD
